1. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
   Arunaksharan Narayanankutty, 2019, Current Drug Targets CrossRef
2. Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
   Xianbo Wu et al, 2022, Frontiers in Pharmacology CrossRef
3. Targeting Protein Synthesis in Colorectal Cancer
   Stefanie Schmidt et al, 2020, Cancers CrossRef
4. Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
   Chenxing Wang et al, 2022, BMC Cancer CrossRef
5. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways
   Bihui Li et al, 2022, Frontiers in Pharmacology CrossRef
6. Weighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism
   Yongting Luo et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
7. Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer
   Yu-Hsuan Chen et al, 2019, Cancers CrossRef
8. Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells
   Pratim Chowdhury et al, 2021, Scientific Reports CrossRef
9. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence
   Arunaksharan Narayanankutty et al, 2023, Recent Patents on Anti-Cancer Drug Discovery CrossRef
10. Structural Aspects of mTOR Inhibitors: Search for Potential Compounds
    Kamalpreet Kaur et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef